Research News and Research

RSS

Spectranetics revenue increases 5% to $30.4 million for first quarter 2011

Spectranetics Corporation today reported financial results for the quarter ended March 31, 2011.

27 Apr 2011

Watson reports net revenue of $876.5 million for first quarter 2011

Watson Pharmaceuticals, Inc. today reported net revenue of $876.5 million for the first quarter ended March 31, 2011, compared to $856.5 million in the first quarter 2010.

27 Apr 2011

Rwanda launches Africa's first nationwide cervical cancer vaccination, detection program

Rwandan First Lady Jeannette Kagame on Tuesday, in collaboration with two companies, launched a national cervical cancer vaccination and screening program, the first of its kind in Africa, the New Times reports.

27 Apr 2011

New discoveries on polycystin-1 can lead to novel kidney disease treatment

Two discoveries at UC Santa Barbara point to potential new drug therapies for patients with kidney disease. The findings are published in this week's issue of the Proceedings of the National Academy of Sciences.

27 Apr 2011

MSF letter criticizes Johnson & Johnson for not joining Medicines Patent Pool

Medecins Sans Frontieres recently sent a letter to Johnson & Johnson criticizing the pharmaceutical company for "refusing to make patents on three HIV drugs available to a program that would reduce the cost of the medicines in developing countries," the Star-Ledger reports.

27 Apr 2011

Riverain Medical's bone suppression technology effective for lung nodule detection

Riverain Medical, an industry leader and innovator in computer-aided detection and advanced visualization technologies, today announced the publication of a peer-reviewed observer study in the May 2011 issue of the American Journal of Roentgenology.

27 Apr 2011

High Court hears arguments regarding access to docs' prescribing data

In this case, the state of Vermont is battling drug companies and data-mining firms. Vermont's law bans the sale of prescribing information unless physicians "opt in" and make their records available.

27 Apr 2011

Proteostasis acquires Harvard University's two novel protein target licenses

Proteostasis Therapeutics announced today that it has acquired two exclusive licenses from Harvard University to technologies for enhancing the activity of a key cellular protein clearance mechanism, the ubiquitin-proteasome pathway.

27 Apr 2011

JumpStart Ventures invests $250,000 in SPR Therapeutics

JumpStart Ventures, a nonprofit that invests in and partners with innovative, early-stage companies in Northeast Ohio, announced an investment commitment of $250,000 in SPR Therapeutics.

27 Apr 2011

AACN to host annual NTI conference for nurses

Emerging trends in patient care combine with advances in healthcare technology as thousands of nurses who care for acutely and critically ill patients gather in Chicago this month.

27 Apr 2011

Santorum says health law fuels interest in possible presidential bid

Des Moines Register: Santorum Says Health Law Has Fueled Possible Campaign.

27 Apr 2011

Court's rejection of fast-track request raises questions, issues

The court's online order did not offer any legal reasoning, nor were dissenting opinions noted. However, Justice Elena Kagan did participate in the decision. Meanwhile, Politico Pro explores some of the key questions that will be at stake surrounding the law's "individual mandate" as the challenges now wind through through the federal appeals courts this summer.

27 Apr 2011

CESAR, Saladax begin patient enrollment in paclitaxel CEPAC-TDM trial for NSCLC

In collaboration with Saladax Biomedical, Inc., the Central European Society for Anticancer Drug Research announced today that enrollment has begun in the CEPAC-TDM trial of paclitaxel therapeutic drug management with subsequent pharmacokinetic-guided dose adjustment in patients being treated for advanced non-small cell lung cancer.

27 Apr 2011

Reform policy news: High-risk pools, exchanges, IPAB

News outlets are reporting on various aspects of the health law, including the low level of interest seen so far in high-risk pools, the varying reactions states are having as they make decisions about health insurance exchanges and the ongoing efforts to repeal the measure's Independent Payment Advisory Board.

27 Apr 2011

Karo Bio reports net loss of MSEK 47.7 for January - March 2011

Karo Bio: The January - March 2011 period in brief. Net sales amounted to MSEK 0.0.

27 Apr 2011

ISCO completes first series of hepatocytes preclinical testing

International Stem Cell Corporation announces successful completion of the first series of preclinical testing of hepatocytes derived in the lab from human parthenogenetic stem cells.

27 Apr 2011

Major breakthrough in understanding of amyotrophic lateral sclerosis

Brandeis researchers have made a significant advance in the effort to understand amyotrophic lateral sclerosis by successfully reversing the toxicity of the mutated protein in the familial type of the disease.

27 Apr 2011

Nationwide researchers to launch Oncotype DX test phase III trial in breast cancer

Cancer researchers at hundreds of sites nationwide are about to launch a SWOG-led clinical trial that could keep thousands of breast cancer patients from getting chemotherapy that is unlikely to do them any good.

27 Apr 2011

Dems eye Ryan Medicare plan as political opportunity

With Obama administration officials part of the campaign against the Ryan plan, other opponents also are stepping forward and launching a new wave of television ads in Wisconsin Republican Rep. Paul Ryan's very own congressional district. Meanwhile, The Washington Post analyzes some of the poll numbers behind where voters may stand on Medicare cuts.

27 Apr 2011

Researchers investigate new device that can recognize early heart attack signs

When a heart attack begins, a stopwatch starts. With each passing minute heart tissue is deprived of blood, causing it to deteriorate or die. In order to minimize damage to the heart, blood flow must be restored promptly, or the effects can be serious, often even fatal.

27 Apr 2011